World's Best Scientists 2026 revealed!
Pharmacological Reviews
H-index 51

Pharmacological Reviews

0031-6997

Published by: American Society for Pharmacology and Experimental Therapeutics

https://pharmrev.aspetjournals.org/

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 461 86 65 37

Additional Metrics

Number of Best Scientists*: 244
Documents by Best Scientists*: 138
Top 100 Ranked Scientists*: 7
SCIMAGO H-index: 264
SCIMAGO SJR: 6.603
Impact Factor: 17.3

Overview

Top Research Topics at Pharmacological Reviews?

The concepts of Pharmacology, Receptor, Neuroscience, Internal medicine and Biochemistry are tackled in Pharmacological Reviews. Drug is the primary subject of Pharmacology works presented in Pharmacological Reviews. The studies tackled, which mainly focus on Receptor, apply to Signal transduction as well.

The Signal transduction study which was featured in it aims to expound on the research in Cell biology. Central nervous system and Dopamine are among the areas of Neuroscience tackled. The study on Internal medicine presented is investigated in conjunction with research in Endocrinology.

Hormone is a key component of Endocrinology research discussed in it. Metabolism and Enzyme are all aspects of Biochemistry discussed in it.

  • Pharmacology (28.50%)
  • Receptor (15.90%)
  • Neuroscience (14.92%)

What are the most cited papers published in the journal?

  • NITRIC OXIDE: PHYSIOLOGY, PATHOPHYSIOLOGY, AND PHARMACOLOGY (14592 citations)
  • International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels (7249 citations)
  • The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer (4014 citations)

Research areas of the most cited articles at Pharmacological Reviews:

The published papers investigate areas of study like Pharmacology, Receptor, Biochemistry, Internal medicine and Endocrinology. Pharmacology research is the primary subject tackled in the most cited papers with a focus in Drug. The most cited publications facilitate discussions on Receptor that incorporate concepts from other fields like Text mining, Signal transduction, Neuroscience and Function (biology).

What topics the last edition of the journal is best known for?

  • Gene
  • Enzyme
  • Internal medicine

The previous edition focused in particular on these issues:

The aim of Pharmacological Reviews is to expand the discussion of research in Bioinformatics, Drug, Neuroscience, Receptor and Disease. Topics in Bioinformatics explored in the journal were investigated in conjunction with research in Drug development and Review article. Dopamine research are fields of study within Neuroscience but they also intertwine with concepts in Signal fidelity.

Receptor research featured in it incorporates concerns from various other topics such as Function (biology) and Clinical pharmacology. The journal explores topics in Disease which can be helpful for research in disciplines like Functional studies, Immunology and Neuroprotection. The overlapping concepts between Retinoid X receptor and Pharmacology are the key highlights of Inflammation study.

The most cited articles from the last journal are:

  • International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function (23 citations)
  • Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development. (19 citations)
  • Subcellular Organization of the cAMP Signaling Pathway. (15 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Pharmacological Reviews (based on the number of publications) are:

  • Taha Nazir (23 papers) published 2 papers at the last edition the same number as at the previous edition,
  • Michael Spedding (12 papers) absent at the last edition,
  • Geoffrey Burnstock (9 papers) absent at the last edition,
  • Tom I. Bonner (9 papers) absent at the last edition,
  • Anthony P. Davenport (9 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Pharmacological Reviews (based on the number of publications) are:

  • National Institutes of Health (55 papers) published 1 paper at the last edition,
  • University of California, San Francisco (19 papers) absent at the last edition,
  • University of North Carolina at Chapel Hill (18 papers) published 1 paper at the last edition,
  • University of Michigan (15 papers) published 1 paper at the last edition,
  • French Institute of Health and Medical Research (15 papers) published 2 papers at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 16.67% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 16.67% were posted by at least one author from the top 10 institutions publishing in the journal. Another 16.67% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 23.33% of all publications and 43.33% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Pharmacology

In the world of healthcare, pharmacology plays a significant role not only in research but also in patient care. Pharmacology experts can be found across various roles in the healthcare industry, such as pharmacy technicians, pharmacists, and nurse practitioners with a deep understanding of pharmaceuticals. For example, becoming a nurse practitioner in Oregon with a background in pharmacology can be a rewarding career path. Nurse practitioners, in most cases, can prescribe medication and need a vast knowledge in pharmacology. The integration of pharmacology and other subjects like Biochemistry, Neuroscience, and Internal medicine can provide an upper hand in diagnosing and treating diseases effectively. If you're interested in further exploring the career of a nurse practitioner, you can follow this comprehensive guide on how to be a nurse practitioner in Oregon. The guide provides an in-depth understanding of the qualifications, certifications, and skills needed to be successful in this currently high-demand role in Oregon. Whether you choose to delve into research or patient care, a career in pharmacology promises a fulfilling experience contributing to the advances of healthcare and betterment of society.

Top Publications

  • Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options.

    Wolfgang Löscher;Heidrun Potschka;Sanjay M. Sisodiya;Annamaria Vezzani

    (2020)
    774 Citations
  • Is Oxytocin “Nature’s Medicine”?

    C. Sue Carter;William M. Kenkel;Evan L. MacLean;Steven R. Wilson

    (2020)
    364 Citations
  • Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials

    (2022)
    330 Citations
  • International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function

    Nicholas M. Barnes;Gerard P. Ahern;Carine Becamel;Joël Bockaert

    (2021)
    236 Citations
  • Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution

    Uddalak Bharadwaj;Moses M. Kasembeli;Prema Robinson;David J. Tweardy

    (2020)
    228 Citations
  • Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

    George F. Koob

    (2021)
    215 Citations
  • The Noncanonical Pathway for In Vivo Nitric Oxide Generation: The Nitrate-Nitrite-Nitric Oxide Pathway.

    V. Kapil;R. S. Khambata;D. A. Jones;K. Rathod

    (2020)
    163 Citations
  • Patient and Disease-Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics.

    David T. Paik;Mark Chandy;Joseph C. Wu

    (2020)
    154 Citations
  • Sex- and Gender-Based Pharmacological Response to Drugs.

    Franck Mauvais-Jarvis;Heiner K. Berthold;Ilaria Campesi;Juan Jesus Carrero

    (2021)
    121 Citations
  • Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.

    Peter Garred;Andrea J. Tenner;Tom E. Mollnes

    (2021)
    119 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their healthcare expertise beyond traditional medical degrees, several online programs offer flexible and accelerated options. A fast track nutrition degree online is an excellent choice for students passionate about dietetics and wellness, providing a swift route to enter the healthcare field with a specialized focus.

Healthcare professionals aiming to move into leadership roles often pursue advanced degrees like an MBA. Exploring the healthcare mba cost can help prospective students find programs that balance quality education with affordability, making managerial careers more accessible.

For non-nurses seeking to transition into nursing, accelerated bsn programs for non nurses offer a streamlined path to earning a Bachelor of Science in Nursing. These programs are designed to equip graduates with the skills required to excel in clinical roles.

Career outlook is also a critical consideration. For example, a psychiatric mental health nurse practitioner salary varies by location, reflecting demand and cost of living, but generally indicates strong earning potential in this growing specialty.

Best Scientists Contributing to This Journal

Recently Published Articles